Results 211 to 220 of about 14,437,638 (295)

IQDMA disrupts STAT5 nuclear transport through CDC42-PAK2 axis collapse in cutaneous T-cell lymphoma. [PDF]

Front Immunol
Dey S, Sorger H, Schlederer M, Perchthaler I, Metzelder M, Kenner L, Moriggl R, Wolf P.   +7 more
europepmc   +1 more source

Oncogenic Mutations and Tumor Microenvironment Alterations in Diffuse Large B‐Cell Lymphoma With Bulky Disease

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Bulky disease represents a clinically aggressive subset of diffuse large B‐cell lymphoma (DLBCL) associated with adverse clinical outcomes. The aim of this study was to investigate the influence of oncogenic mutations and tumor microenvironment alterations on bulky disease in DLBCL.
Yu‐Qing Wang, Yue Wang, Zhi‐Shan Du, Xin‐Yun Huang, Yan Dong, Shuang Tian, Di Fu, Shu Cheng, Li Wang, Peng‐Peng Xu, Sheng‐Jin Fan, Shu‐Ye Wang   +11 more
wiley   +1 more source

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma. [PDF]

Cancer Sci
Takahashi Y, Kitadate A, Iwama S, Kuroki W, Abe K, Yamada M, Ikeda S, Tagawa H, Wakui H, Hikida M, Takahashi N.   +10 more
europepmc   +1 more source

Target‐Specific Dermatological Adverse Event Reporting With T‐Cell–Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016–2026

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background T‐cell–engaging bispecific antibodies are increasingly utilised in haematological malignancies and are beginning to be adopted in solid‐tumour treatment protocols. Cytokine release syndrome and neurotoxicity are well recognised, but target‐specific dermatological adverse event reporting patterns remain poorly defined.
Saikat Mandal, Manideepa Maji, Arkadeep Dhali   +2 more
wiley   +1 more source

Non-<i>JAK</i>-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets. [PDF]

Haematologica
Stuver R, Tang H, Dogan A, Epstein-Peterson ZD, Geller S, Ghione P, Johnson WT, Moskowitz A, Moy A, Virgen CA, Horwitz SM, Pulitzer M.   +11 more
europepmc   +1 more source

Histone Post‐Translational Modifications Regulating Ferroptosis: The Molecular Mechanisms and Disease Associations

Cell Biochemistry and Function, Volume 44, Issue 9, September 2026.
ABSTRACT Ferroptosis is a form of programmed cell death characterized by iron‐dependent phospholipid peroxidation and is implicated in a wide range of human diseases. Emerging evidence highlights the critical role of epigenetic regulation in this process.
Xiaoqian Tang, Haodang Luo, Siqi Gao, Xiaocheng Liu, Qing Sun, Yanhua Zeng   +5 more
wiley   +1 more source

Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma. [PDF]

Allergy
Gluud M, Pallesen EM, Zeng Z, Namini MRJ, Vadivel CK, Gjerdrum LMR, Yan L, Ahmad S, Lindahl LM, Bzorek M, Kamstrup MR, Dey S, Ostrowski SR, Sørensen E, Rantakari P, Bonefeld CM, Geisler C, Woetmann A, Lahesmaa R, Iversen L, Wolf P, Litman T, Buus TB, Ødum N.   +23 more
europepmc   +1 more source

Squamous Cell Carcinoma Arising in a Mature Cystic Teratoma of the Ovary Presenting With a Ruptured Sister Mary Joseph Nodule: A Rare Case Report From Northern Tanzania

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Squamous cell carcinoma arising from malignant transformation of a mature cystic teratoma is an exceptionally rare ovarian malignancy, and metastatic umbilical involvement is particularly uncommon. Diagnosis and treatment planning are challenging due to overlapping presentation with epithelial ovarian cancer, particularly in settings with ...
John Lugata, Caleigh Smith, Onesmo Mrosso, Jaynes Kabuhaya, Lily Severn, Krizia Nsoh Nji, Tecla Lyamuya, Elizabeth Skinner, Gilbert Nkya, Eusebious Maro, Alex Mremi, Bariki Mchome   +11 more
wiley   +1 more source

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis. [PDF]

J Dtsch Dermatol Ges
Schummer P, Glatzel C, Schrüfer P, Lawrenz I, Dobos G, Wehkamp U, Hüning S, Stranzenbach R, Nicolay JP, Goebeler M, Wobser M.   +10 more
europepmc   +1 more source

Oral Relapsing Lymphomatoid Papulosis: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Lymphomatoid papulosis (LyP) is a CD30+ T‐cell lymphoproliferative disorder rarely involving mucosa, where it may mimic aggressive lymphomas. This case highlights its chronic relapsing course, diagnostic challenges with ALK‐negative anaplastic T‐cell lymphoma, and the importance of long‐term follow‐up despite a favorable prognosis.
A. Bitton, P. Le Gatt, S. Barete, L. Eck, P. Reimbold, G. Lescaille, N. Gauthier, J. Rochefort   +7 more
wiley   +1 more source